Search Results - "Salgia, Reena J."

Predictors of Waitlist Mortality in Portopulmonary Hypertension by DuBrock, Hilary M, Goldberg, David S, Sussman, Norman L, Bartolome, Sonja D, Kadry, Zakiyah, Salgia, Reena J, Mulligan, David C, Kremers, Walter K, Kawut, Steven M, Krowka, Michael J, Channick, Richard N

“…BACKGROUNDThe current Organ Procurement Transplantation Network policy grants Model for End-Stage Liver Disease (MELD) exception points to patients with…”
Get full text

Diagnosis and Management of Hereditary Hemochromatosis by Salgia, Reena J., MD, Brown, Kimberly, MD

“…Hereditary hemochromatosis is a rare genetic disorder that can have significant clinical consequences. Hemochromatosis is associated with iron overload, and…”
Get full text

S4386 Atypical Late Presentations of Metastatic Hepatocellular Carcinoma After Liver Transplant by Dababneh, Yara JN, Salgia, Reena J.

Get full text

Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes by DuBrock, Hilary M., Salgia, Reena J., Sussman, Norman L., Bartolome, Sonja D., Kadry, Zakiyah, Mulligan, David C., Jenkins, Sarah, Lackore, Kandace, Channick, Richard N., Kawut, Steven M., Krowka, Michael J.

“…The role of liver transplantation (LT) in the management of portopulmonary hypertension (POPH) is poorly understood. The aim of this study was to better…”
Get full text

Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma by Parikh, Neehar D., Mehta, Neil, Hoteit, Maarouf A., Yang, Ju Dong, John, Binu V., Moon, Andrew M., Salgia, Reena J., Pillai, Anjana, Kassab, Ihab, Saeed, Naba, Thyssen, Emil, Nathani, Piyush, McKinney, Jeffrey, Chan, Wesley, Durkin, Claire, Connor, Matthew, Alsudaney, Manaf, Konjeti, Rajesh, Durand, Brenda, Nissen, Nicholas N., Kim, Hannah P., Paknikar, Raghavendra, Rich, Nicole E., Schipper, Matthew J., Singal, Amit G.

“…Background Sustained viral response (SVR) improves survival for patients with hepatitis C (HCV) and hepatocellular carcinoma (HCC) after curative treatment;…”
Get full text

Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re‐Evaluating Age Limits in Transplantation Consortium by Kwong, Allison J., Devuni, Deepika, Wang, Connie, Boike, Justin, Jo, Jennifer, VanWagner, Lisa, Serper, Marina, Jones, Lauren, Sharma, Rajani, Verna, Elizabeth C., Shor, Julia, German, Margarita N., Hristov, Alexander, Lee, Alexander, Spengler, Erin, Koteish, Ayman A., Sehmbey, Gurbir, Seetharam, Anil, John, Nimy, Patel, Yuval, Kappus, Matthew R., Couri, Thomas, Paul, Sonali, Salgia, Reena J., Nhu, Quan, Frenette, Catherine T., Lai, Jennifer C., Goel, Aparna

“…The liver transplantation (LT) population is aging, with the need for transplant being driven by the growing prevalence of nonalcoholic steatohepatitis (NASH)…”
Get full text

Outcomes of Liver Transplantation for Porto-Pulmonary Hypertension in Model for End-Stage Liver Disease Era by Salgia, Reena J., Goodrich, Nathan P., Simpson, Heather, Merion, Robert M., Sharma, Pratima

“…Porto-pulmonary hypertension (POPH), once considered an absolute contraindication for liver transplantation (LT), has become a more accepted indication because…”
Get full text

Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation by Turgeon, Michael K., Shah, Shimul A., Delman, Aaron M., Tran, Benjamin V., Agopian, Vatche G., Wedd, Joel P., Magliocca, Joseph F., Kim, Ahyoung, Cameron, Andrew, Olyaei, Ali, Orloff, Susan L., Anderson, Matthew P., Kubal, Chandrashekhar A., Cannon, Robert M., Locke, Jayme E., Simpson, Mary A., Akoad, Mohamed E., Wongjirad, Chelsey P., Emamaullee, Juliet, Moro, Amika, Aucejo, Federico, Feizpour, Cyrus A., Vagefi, Parsia A., Nguyen, Mindie H., Esquivel, Carlos O., Dhanireddy, Kiran, Subramanian, Vijay, Chavarriaga, Alejandro, Kazimi, Marwan M., Anderson, Maia S., Sonnenday, Christopher J., Kim, Steven C., Foley, David P., Abdouljoud, Marwan, Salgia, Reena J., Moris, Dimitrios, Sudan, Debra L., Ganesh, Swaytha R., Humar, Abhinav, Doyle, Majella, Chapman, William C., Maithel, Shishir K.

“…Objective: To investigate the optimal timing of direct acting antiviral (DAA) administration in patients with hepatitis C-associated hepatocellular carcinoma…”
Get full text

Improved Post-Transplant Survival in the United States for Patients with Cholangiocarcinoma After 2000 by Salgia, Reena J., Singal, Amit G., Fu, Sherry, Pelletier, Shawn, Marrero, Jorge A.

“…Background The incidence of cholangiocarcinoma (CCA) continues to rise. Orthotopic liver transplantation (OLT) can be used for selected patients with localized…”
Get full text

The educational impact of the Specialty Care Access Network-Extension of Community Healthcare Outcomes program by Salgia, Reena J, Mullan, Patricia B, McCurdy, Heather, Sales, Anne, Moseley, Richard H, Su, Grace L

“…With the aging hepatitis C cohort and increasing prevalence of fatty liver disease, the burden on primary care providers (PCPs) to care for patients with liver…”
Get more information

Donor Factors Similarly Impact Survival Outcome After Liver Transplantation in Hepatocellular Carcinoma and Non-hepatocellular Carcinoma Patients by Salgia, Reena J., Goodrich, Nathan P., Marrero, Jorge A., Volk, Michael L.

“…Background Many have advocated the preferential use of high risk allografts for hepatocellular carcinoma patients undergoing liver transplantation…”
Get full text